Detalhe da pesquisa
1.
Publisher Correction: Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection.
Nat Immunol
; 21(9): 1135, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620862
2.
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.
Nat Immunol
; 17(5): 593-603, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26950238
3.
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
Gut
; 73(6): 1015-1024, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527788
4.
BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes.
Am J Physiol Cell Physiol
; 326(3): C880-C892, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223924
5.
Endoscopic procedures in hepatology: Current trends and new developments.
J Hepatol
; 80(1): 124-139, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730125
6.
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
J Hepatol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428644
7.
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases.
J Hepatol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552880
8.
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving ß-blockers+ligation to prevent re-bleeding.
J Hepatol
; 80(1): 73-81, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852414
9.
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
Gastroenterology
; 164(7): 1248-1260, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849086
10.
Controversies regarding albumin therapy in cirrhosis.
Hepatology
; 2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540192
11.
Noninvasive assessment of hepatic decompensation.
Hepatology
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801593
12.
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS.
Hepatology
; 77(2): 466-475, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869810
13.
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.
Hepatology
; 77(4): 1228-1240, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993369
14.
Acute and non-acute decompensation of liver cirrhosis (47/130).
Liver Int
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426268
15.
Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.
BMC Gastroenterol
; 24(1): 145, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664624
16.
The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.
Int J Mol Sci
; 25(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338821
17.
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Gut
; 73(1): 156-165, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884354
18.
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.
Gut
; 72(4): 749-758, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328772
19.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788059
20.
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Gut
; 72(8): 1581-1591, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788015